MétaCan
Menu
Back to cohort
Record W4411329812 · doi:10.1001/jama.2025.7817

Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity

2025· article· en· W4411329812 on OpenAlexafffund
Alexis Moscoso, Fiona Heeman, Sheelakumari Raghavan, Alejandro Costoya‐Sánchez, Martijn van Essen, Ismini Mainta, Valle Camacho, Omar Darío Rodríguez-Fonseca, Jesús Silva‐Rodríguez, Andrés Perissinotti, Yuna Gu, Jihwan Yun, Débora Elisa Peretti, Federica Ribaldi, Emma M. Coomans, Wagner S. Brum, Michel J. Grothe, Pablo Aguiar, Gérard N. Bischof, Alexander Drzezga, Sang Won Seo, Sylvia Villeneuve, Maura Malpetti, John T. O’Brien, James B. Rowe, Elsmarieke van de Giessen, Rik Ossenkoppele, William Jagust, Ruben Smith, Oskar Hansson, Giovanni B. Frisoni, Valentina Garibotto, David N. Soleimani‐Meigooni, Marı́a C. Carrillo, Bradford C. Dickerson, Renaud La Joie, Gil D. Rabinovici, Liana G. Apostolova, Pamela LaMontagne, Michael J. Pontecorvo, Keith A. Johnson, Reisa A. Sperling, Michael W. Weiner, Ronald C. Petersen, Clifford R. Jack, Prashanthi Vemuri, Michael Schöll, Angela Tam, Anne Labonté, Alexa Pichet Binette, Anne‐Marie Faubert, Axel Mathieu, Cécile Madjar, Charles Edouard Carrier, Christian Dansereau, Christina Kazazian, Claude Lepage, Cynthia Picard, David Maillet, Diane Michaud, Doris Couture, Doris Dea, A. Claudio Cuello, Alan Barkun, Alan C. Evans, Blandine Courcot, Christine Tardif, Clément Debacker, David Fontaine, David S. Knopman, Gerhard Multhaup, Jamie Near, Jeannie‐Marie Leoutsakos, Jean‐Robert Maltais, Jason Brandt, Jens C. Pruessner, John C. Morris, John C.S. Breitner, Judes Poirier, Laksanun Cheewakriengkrai, D. Louis Collins, M. Mallar Chakravarty, Mark A. Sager, Marina Dauar‐Tedeschi, Mark J. Eisenberg, Natasha Rajah, Paul Aisen, Paule‐Joanne Toussaint, Pedro Rosa‐Neto, Bellec Pierre, Penelope Kostopoulos, Pierre Étienne, Pierre N. Tariot, Pierre Orban, Rick Hoge, Ronald J. Thomas, Serge Gauthier, Suzanne Craft, Thomas J. Montine, Vasavan Nair, Véronique D. Bohbot, Vinod Venugopalan, Vladimir Fonov, Yasser Ituria‐Medina, Zaven S. Khachaturian, Eduard Teigner, Elena Anthal, Elsa Yu, Fabiola Ferdinand, Galina Pogossova, Ginette Mayrand, Guerda Duclair, Guylaine Gagné, Holly Newbold‐Fox, Illana Leppert, Isabelle Vallée, Jacob W. Vogel, Jennifer Tremblay‐Mercier, Joanne Frenette, Josée Frappier, Justin Kat, Justin Miron, Karen Wan, Laura Mahar, Leopoldina Carmo, Louise Théroux, Mahsa Dadar, Marianne Dufour, Marie‐Élyse Lafaille‐Magnan, Melissa Appleby, Mélissa Savard, Miranda Tuwaig, Mirela Petkova, Pierre Rioux, P.T. Meyer, Rana El‐Khoury, Renee Gordon, Renuka Giles, Samir Das, Seqian Wang, Shirin Tabrizi, Sulantha Mathotaarachchi, Sylvie Dubuc, Tanya Lee, Thomas Beaudry, Valérie Gervais, Véronique Pagé, Julie Gonneaud, Tharick A. Pascoal, René Desautels, Fatiha Benbouhoud, Eunice Farah Saint‐Fort, Sander C.J. Verfaillie, Sarah Farzin, Alyssa Salaciak, Stéphanie Tullo, Étienne Vachon‐Presseau, Leslie‐Ann Daoust, Theresa Köbe, R. Nathan Spreng, Melissa McSweeney, Nathalie Nilsson, Morteza Pishnamazi, Christophe Bedetti, Louise Hudon, Claudia Greco, Marianne Chapleau, Frédéric St‐Onge, Sophie Boutin, Maiya R. Geddes, Simon Ducharme, Gabriel Jean, Elisabeth Sylvain, Marie‐Josee Élie, Gloria Leblond‐Baccichet, Jean‐Paul Soucy, Hazal Ozlen, Julie Bailly, Béry Mohammediyan, Yalin Chen, Jordana Remz, Dorene M. Rentz, Rebecca E. Amariglio, Deborah Blacker, Rachel F. Buckley, Jasmeer P. Chhatwal, Brad C. Dickerson, Nancy J. Donovan, Michelle E. Farrell, Geoffroy Gagliardi, Jennifer R. Gatchel, Edmarie Guzmán‐Vélez, Heidi I.L. Jacobs, Roos J. Jutten, Cristina Lois Gómez, Gad A. Marshall, Kate Oaoo, Enmanuelle Pardilla‐Delgado, Julie Price, Prokopis C. Prokopiou, Yakeel T. Quiroz, Gretchen Reynolds, Aaron P. Schultz, Stephanie A. Schultz, Jorge Sepulcre, Irina A. Skylar-Scott, Patrizia Vannini, Clara Vila‐Castelar, Hyun‐Sik Yang, John Q. Trojanowki, Arthur W. Toga, Laurel Beckett, Robert C Green, Andrew J. Saykin, Richard J. Perrin, Leslie M. Shaw, William Z. Potter, Lisa L. Barnes, Marie Bernard, Héctor Alfredo Baptista González, Carole Ho, John Hsiao, Jonathan Jackson, Eliezer Masliah, Donna Masterman, Laurie Ryan, Nina Silverberg, Adam Fleisher, Juliet Fockler, Cat Conti, Dallas P. Veitch, John Neuhaus, Chengshi Jin, Rachel L. Nosheny, Mariam Ashford, Derek Flenniken, Adrienne Kormos, Tom Montine, Michael Rafii, Rema Raman, Gustavo Jimenez‐Maggiora, Michael Donohue, Devon Gessert, Jennifer Salazar, Caileigh Zimmerman, Yuliana Cabrera, Sarah Walter, Garrett Miller, Godfrey Coker, Taylor Clanton, Lindsey Hergesheimer, Stephanie Smith, Olusegun Adegoke, Payam Mahboubi, Shelley Moore, Jeremy Pizzola, Elizabeth Shaffer, Danielle Harvey, Arvin Forghanian-Arani, Bret Borowski, Chad Ward, Christopher G. Schwarz, David T. Jones, Jeff Gunter, Kejal Kantarci, Matthew L. Senjem, Robert I. Reid, Nick C. Fox, Ian B. Malone, Paul Thompson, Sophia I. Thomopoulos, Talia M. Nir, Neda Jahanshad, Charles DeCarli, Alexander Knaack, Evan Fletcher, Duygu Tosun, Stephanie R Chen, Mark Choe, Karen Crawford, Paul A Yuschkevich, Sandhitsu R. Das, Robert A. Koeppe, Eric M. Reiman, Kewei Chen, Susan Landau, Nigel J. Cairns, Erin Householder, Erin Franklin, Haley Bernhardt, Lisa Taylor‐Reinwald, Magdalena Korecka, Michal Figurski, Scott Neu, Kwangsik Nho, Shannon L. Risacher, Li Shen, Tatiana M. Foroud, Kelly Nudelman, Kelley Faber, Kristi Wilmes, Leon J. Thal, Jeffrey L. Dage, Ani Eloyan, Bernardino Ghetti, Lea T. Grinberg, Dustin B. Hammers, Kala Kirby, Joel Kramer, Walter A. Kukull, Julien Legarde, Melissa E. Murray, Kathy L. Newell, Angelina J. Polsinelli, Alexander Taurone, Maryanne Thangarajah, Alexandra Touroutoglou, Alireza Atri, David Clark, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Ian Grant, Lawrence S. Honig, Erik C. B. Johnson, Joseph C. Masdeu, Mario F. Mendez, Erik S. Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalskı, Steven Salloway, Sharon J. Sha, Raymond Scott Turner, Thomas S. Wingo, S. J. Wolk, Kyle Womack

Bibliographic record

VenueJAMA · 2025
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsMcGill Genome CentreMcGill UniversityDouglas Mental Health University Institute
FundersLawrence Berkeley National LaboratoryDepartment of Radiology and Biomedical Imaging, University of California, San FranciscoNational Center for Advancing Translational SciencesNational Center for Research ResourcesNational Institute on Deafness and Other Communication DisordersNational Institute of Mental HealthNational Institute on AgingSahlgrenska AkademinKorea National Institute of HealthMedical Research CouncilCharles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. LouisHORIZON EUROPE Framework ProgrammePfizer CanadaUniversity of California, San FranciscoNational Institutes of HealthNational Center for Geriatrics and GerontologyNational Institute of Neurological Disorders and StrokeDeutsches Zentrum für Neurodegenerative ErkrankungenTaipei Medical UniversityKnut och Alice Wallenbergs StiftelseVetenskapsrådetSamsungUniversity of Southern CaliforniaEisaiUK Dementia Research InstituteNational Research Foundation of KoreaKorea Health Industry Development InstituteLunds UniversitetNovo NordiskAvid RadiopharmaceuticalsSchool of Medicine, Indiana UniversityWashington University in St. LouisCambridge University HospitalsGöteborgs UniversitetNational Institute for Health and Care ResearchNational Research FoundationGovernment of CanadaUniversity of CambridgeSungkyunkwan UniversityGenentechEuropean CommissionGHR FoundationInstitute for Information and Communications Technology PromotionProthenaUniversität zu KölnSahlgrenska UniversitetssjukhusetUniversity of OxfordNational Institute of Biomedical Imaging and BioengineeringSkånes universitetssjukhusCalifornia Department of Public HealthFaculty of Medicine, McGill UniversityLarry L. Hillblom FoundationACADIA PharmaceuticalsAustralian Catholic UniversityU.S. Department of DefenseEli Lilly and CompanyDemensförbundetAlexander Family FoundationWallenberg Centre for Molecular and Translational MedicineDeutsche ForschungsgemeinschaftMcGill UniversityPfizerBiogenNational Institute of Allergy and Infectious DiseasesBioClinicaUniversity College LondonMinistry of Science and ICT, South KoreaWellcome TrustMassachusetts General HospitalBrigham and Women's HospitalAlzheimer's AssociationCleveland ClinicBristol-Myers SquibbApellis PharmaceuticalsU.S. Department of Veterans AffairsAlzheimer's Disease Neuroimaging Initiative
KeywordsMedicinePositron emission tomographyPositron emissionTomographyNuclear medicineMedical physicsRadiology

Abstract

fetched live from OpenAlex

Importance: Tau positron emission tomography (PET) allows in vivo detection of neurofibrillary tangles, a core neuropathologic feature of Alzheimer disease (AD). Objective: To provide estimates of the frequency of tau PET positivity and its associated risk of clinical outcomes. Design, Setting, and Participants: Longitudinal study using data pooled from 21 cohorts, comprising a convenience sample of 6514 participants from 13 countries, collected between January 2013 and June 2024. Cognitively unimpaired individuals and patients with a clinical diagnosis of mild cognitive impairment (MCI), AD dementia, or other neurodegenerative disorders were included. Exposures: Tau PET with flortaucipir F 18, amyloid-β (Aβ) PET, and clinical examinations. Tau PET scans were visually rated as positive according to a US Food and Drug Administration- and European Medicines Agency-approved method, designed to indicate the presence of advanced neurofibrillary tangle pathology (Braak stages V-VI). Main Outcomes and Measures: Frequency of tau PET positivity and absolute risk of clinical progression (eg, progression to MCI or dementia). Results: Among the 6514 participants (mean age, 69.5 years; 50.5% female), median follow-up time ranged from 1.5 to 4.0 years. Of 3487 cognitively unimpaired participants, 349 (9.8%) were tau PET positive; the estimated frequency of tau PET positivity was less than 1% in those aged younger than 50 years, and increased from 3% (95% CI, 2%-4%) at 60 years to 19% (95% CI, 16%-24%) at 90 years. Tau PET positivity frequency estimates increased across MCI and AD dementia clinical diagnoses (43% [95% CI, 41%-46%] and 79% [95% CI, 77%-82%] at 75 years, respectively). Most tau PET-positive individuals (92%) were also Aβ PET positive. Cognitively unimpaired participants who were positive for both Aβ PET and tau PET had a higher absolute risk of progression to MCI or dementia over the following 5 years (57% [95% CI, 45%-71%]) compared with both Aβ PET-positive/tau PET-negative (17% [95% CI, 13%-22%]) and Aβ PET-negative/tau PET-negative (6% [95% CI, 5%-8%]) individuals. Among participants with MCI at the time of the tau PET scan, an Aβ PET-positive/tau PET-positive profile was associated with a 5-year absolute risk of progression to dementia of 70% (95% CI, 59%-81%). Conclusions and Relevance: In a large convenience sample, a positive tau PET scan occurred at a nonnegligible rate among cognitively unimpaired individuals, and the combination of Aβ PET positivity and tau PET positivity was associated with a high risk of clinical progression in both preclinical and symptomatic stages of AD. These findings underscore the potential of tau PET as a biomarker for staging AD pathology.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.024
Threshold uncertainty score0.295

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.349
Teacher spread0.335 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations44
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJAMASame topicDementia and Cognitive Impairment ResearchFrench-language works237,207